Abstract:The activation levels of biologically significant gene sets are emerging tumor molecular markers and play an irreplaceable role in the tumor research field; however, web-based tools for prognostic analyses using it as a tumor molecular marker remain scarce. We developed a web-based tool PESSA for survival analysis using gene set activation levels. All data analyses were implemented via R. Activation levels of The Molecular Signatures Database (MSigDB) gene sets were assessed using the single sample gene set enrichment analysis (ssGSEA) method based on data from the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), The European Genome-phenome Archive (EGA) and supplementary tables of articles. PESSA was used to perform median and optimal cut-off dichotomous grouping of ssGSEA scores for each dataset, relying on the survival and survminer packages for survival analysis and visualisation. PESSA is an open-access web tool for visualizing the results of tumor prognostic analyses using gene set activation levels. A total of 238 datasets from the GEO, TCGA, EGA, and supplementary tables of articles; covering 51 cancer types and 13 survival outcome types; and 13,434 tumor-related gene sets are obtained from MSigDB for pre-grouping. Users can obtain the results, including Kaplan–Meier analyses based on the median and optimal cut-off values and accompanying visualization plots and the Cox regression analyses of dichotomous and continuous variables, by selecting the gene set markers of interest. PESSA (https://smuonco.shinyapps.io/PESSA/ OR http://robinl-lab.com/PESSA) is a large-scale web-based tumor survival analysis tool covering a large amount of data that creatively uses predefined gene set activation levels as molecular markers of tumors. The activation levels of biologically significant gene sets are emerging tumor molecular markers and play an irreplaceable role in the tumor research field; however, web-based tools for prognostic analyses using it as a tumor molecular marker remain scarce. PESSA is an open-access web tool for visualizing the results of tumor prognostic analyses using gene set activation levels. A total of 238 datasets from the GEO, TCGA, EGA, and supplementary tables of articles; covering 51 cancer types and 13 survival outcome types; and 13,434 tumor-related gene sets are obtained from MSigDB for pre-grouping. Users can obtain the results, including Kaplan–Meier analyses based on the median and optimal cut-off values and visualization plots and the Cox regression analyses of dichotomous and continuous variables, by selecting the gene set markers of interest. Freely available on the web at https://smuonco.shinyapps.io/PESSA/ OR http://robinl-lab.com/PESSA. Website implemented in R Shiny, with major browsers supported.

P-Sage: Parametric Statistical Analysis of Gene Sets*

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Analyzing Gene Expression Data in Terms of Gene Sets: Gene Set Enrichment Analysis

PESSA: A web tool for pathway enrichment score-based survival analysis in cancer

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Advance of SAGE and its Application in the CNS Tumors

Bayesian Gene Set Analysis

GAGE: generally applicable gene set enrichment for pathway analysis

PLS-based gene subset augmentation and tumor-specific gene identification

IGSA: Individual Gene Sets Analysis, Including Enrichment and Clustering.

Implications of Serial Analysis of Gene Expression for Cancer Research

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Improving GSEA for Analysis of Biologic Pathways for Differential Gene Expression Across a Binary Phenotype

DBGSA: a novel method of distance-based gene set analysis

Finding significant gene sets with weighted distribution of gene expression

GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels

Principle and Progression of Serial Analysis of Gene Expression and Its Application in Tumor Study

Gene set based systematic analysis of prostate cancer and its subtypes.

Gene Set Enrichment Analysis (GSEA) for Interpreting Gene Expression Profiles

Integration of Statistical Inference Methods and a Novel Control Measure to Improve Sensitivity and Specificity of Data Analysis in Expression Profiling Studies

Pathway-based feature selection algorithms identify genes discriminating patients with multiple sclerosis apart from controls